Aspartame
(as' par tame).
C14H18N2O5 294.30 l-Phenylalanine, N-l--aspartyl-, 1-methyl ester; 3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester [22839-47-0]. DEFINITION
Aspartame contains NLT 98.0% and NMT 102.0% of C14H18N2O5, calculated on the dried basis.
IDENTIFICATION
• A. Infrared Absorption 197M
[NoteDo not dry specimens. ]
ASSAY
• Procedure
Sample:
300 mg
Titrimetric system
(See Titrimetry 541.)
0.1 N Perchloric acid:
Use perchloric acid, tenth-normal (0.1 N) in glacial acetic acid as specified for Reagents, Indicators, and SolutionsVolumetric Solutions, but in the standardization, titrate to a green endpoint.
Mode:
Direct titration
Titrant:
Use 0.1 N Perchloric acid
Blank:
1.5 mL of anhydrous formic acid and 60 mL of glacial acetic acid
Endpoint detection:
Visual
Analysis:
Dissolve the Sample in 1.5 mL of anhydrous formic acid, and add 60 mL of glacial acetic acid. Add crystal violet, and immediately titrate with the Titrant to a green endpoint. Perform a blank determination. [NoteA blank titration exceeding 0.1 mL may be due to excessive water content, and may cause loss of visual endpoint sensitivity. ]
Calculate the percentage of Aspartame (C14H18N2O5) in the Sample taken:
Result = [(V B) × N × F × 100]/W
Acceptance criteria:
98.0%102.0% on the dried basis
IMPURITIES
• Residue on Ignition 281:
NMT 0.2%
• Heavy Metals, Method II 231:
NMT 10 ppm
• Limit of 5-Benzyl-3,6-dioxo-2-piperazineacetic Acid
Diluent:
Methanol and water (1:9)
Mobile phase:
Dissolve 5.6 g of monobasic potassium phosphate in 820 mL of water in a 1-L volumetric flask, adjust with phosphoric acid to a pH of 4.3, and dilute with methanol to volume.
Standard solution:
75 µg/mL of USP Aspartame Related Compound A RS in Diluent
Sample solution:
5 mg/mL of Aspartame in Diluent
[NoteAvoid heat and excessive holding times. ]
Chromatographic system
Mode:
LC
Detector:
UV 210 nm
Column:
4.6-mm × 25-cm; packing L1
Column temperature:
40
Flow rate:
2 mL/min
Injection size:
20 µL
System suitability
Sample:
Standard solution
Suitability requirements
Tailing factor:
NMT 2.0
Relative standard deviation:
NMT 4.0%
Analysis
Samples:
Standard solution and Sample solution
Calculate the percentage of aspartame related compound A in the portion of Aspartame taken:
Result = (rU/rS) × (CS/CU) × 100
Acceptance criteria:
NMT 1.5%
• Chromatographic Purity
Diluent, Mobile phase, and Chromatographic system:
Proceed as directed in Limit of 5-Benzyl-3,6-dioxo-2-piperazineacetic Acid.
Sample stock solution:
Proceed as directed for Sample solution under Limit of 5-Benzyl-3,6-dioxo-2-piperazineacetic Acid.
Sample solution:
0.1 mg/mL of Aspartame from the Sample stock solution in Diluent
Analysis
Samples:
Sample stock solution and Sample solution
[NoteContinue the elution of Sample stock solution for twice the retention time of the aspartame peak. ]
Acceptance criteria:
The sum of the responses of all the peaks in the chromatogram of the Sample stock solution, excluding the 5-benzyl-3,6-dioxo-2-piperazineacetic acid and aspartame peak responses, is not greater than the aspartame peak response of the Sample solution, corresponding to NMT 2.0% of chromatographic impurities.
SPECIFIC TESTS
• Transmittance
Sample solution:
10 mg/mL of Aspartame in 2 N hydrochloric acid, prepared by means of sonication
Analysis:
Determine the transmittance in a 1-cm cell at 430 nm with a suitable spectrophotometer.
Acceptance criteria:
Transmittance of NLT 0.95, corresponding to an absorbance of NMT about 0.022
• Optical Rotation, Specific Rotation 781S
Sample solution:
40 mg/mL in 15 N formic acid
Acceptance criteria:
+14.5 to +16.5, determined at 20 within 30 min after preparation of the Sample solution
• Loss on Drying 731:
Dry a sample at 105 for 4 h: it loses NMT 4.5% of its weight.
ADDITIONAL REQUIREMENTS
• Packaging and Storage:
Preserve in well-closed containers.
• USP Reference Standards 11
USP Aspartame Related Compound A RS
5-Benzyl-3,6-dioxo-2-piperazineacetic acid. C13H14N2O4 262.27
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 1702
|